Efficacy of Changing to TRAVATAN® From Prior Therapy

Exclusion Criteria

• •Known medical history of allergy, hypersensitivity, or poor tolerance to any component of the preparations to be used in this study deemed clinically significant in the opinion of the Principal Investigator.
• •Any abnormality preventing reliable applanation tonometry in either eye.
• •Severe dry eye or related which has been or currently is being treated with the use of punctal plugs, punctal cautery, Restasis®, or topical ocular corticosteroids.
• •Any clinically significant, serious, or severe medical condition.
• •Intraocular conventional surgery or laser surgery in either eye less than three months prior to Screening Visit.
• •Risk of visual field or visual acuity worsening as a consequence of participation in the study, in the investigator's best judgment.
• •Progressive retinal or optic nerve disease from any cause.
• •Women who are pregnant, lactating.
• •Women not using reliable means of birth control.
• •Use of any systemic medication known to affect IOP which has not been on stable course for at least 7 days prior to Screening Visit.
• •Any clinically significant, serious, or severe medical condition.
• •Participation in any other investigational study within 30 days of Screening Visit.